These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7128804)

  • 41. Fructose-1, 6-diphosphate dependence on the toxicity and uptake of potassium ions.
    Cattani L; Costrini R; Cerilli C; Rigobello MP; Bianchi M; Galzigna L
    Agressologie; 1980; 21(5):263-4. PubMed ID: 7246913
    [No Abstract]   [Full Text] [Related]  

  • 42. Metabolic effects of fructose diphosphate.
    Webb WR
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):948. PubMed ID: 3999795
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of fructose on fructose 2,6-bisphosphate level and fructose 6-phosphate, 2-kinase activity in the perfused rat liver.
    Ogawa A; Nishi T; Furuya E; Watanabe F; Sakai A; Kido Y; Tsujinaka T; Mori T
    Biochem Mol Biol Int; 1993 May; 30(1):83-90. PubMed ID: 8395275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics, blood partition, and tissue distribution of itraconazole.
    Lee JH; Shin JH; Lee MG
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():203-15. PubMed ID: 17564318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats.
    Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH
    J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of fructose-1,6-diphosphate, cytochrome c and their combination on the size of the necrotic area in transient myocardial ischemia].
    Imatdieva RM; Gatsura VV
    Eksp Klin Farmakol; 1997; 60(1):32-4. PubMed ID: 9162279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fructose-1,6-diphosphate administration during extracorporeal circulation. I. Reduction of post-perfusion hemolysis].
    Barberis L; Brisighella A; Lijoi A; Pansini S; Scarano F; Scoti P; Passerone GC; De Gaetano G; Petillo A; Venere G
    Minerva Cardioangiol; 1983 Apr; 31(4):187-9. PubMed ID: 6877618
    [No Abstract]   [Full Text] [Related]  

  • 49. Fructose diphosphate and mean erythrocytic survival after extracorporeal circulation.
    Candiani A; Costrini R; Cifra E; de Santis AM; Lenzi A; Gasparetto A
    Agressologie; 1984 Oct; 25(9):1019-22. PubMed ID: 6507769
    [No Abstract]   [Full Text] [Related]  

  • 50. [Use of fructose-1,6-diphosphate in essential headache. Therapeutic outlook and case study].
    Ferrigno V; Rotolo G; di Fede G; Rizzo G; Gullotti D; Sovarino R; Russo S; Rini GB
    G Clin Med; 1987 Oct; 68(10):515-8. PubMed ID: 3428516
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of fructose-1,6-diphosphate sodium salt (FDP) in burnt patients.
    De Renzis A; Callegaris G; Vasi R
    Agressologie; 1982 Dec; 23(7):321-3. PubMed ID: 6762826
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacokinetics of fructose-1,6-diphosphate after intraperitoneal and oral administration to adult rats.
    Xu K; Stringer JL
    Pharmacol Res; 2008 Mar; 57(3):234-8. PubMed ID: 18325780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic action of fructose-1,6-diphosphate in traumatic shock.
    Markov AK; Oglethorpe N; Grillis M; Neely WA; Hellems HK
    World J Surg; 1983 May; 7(3):430-6. PubMed ID: 6880232
    [No Abstract]   [Full Text] [Related]  

  • 54. [Regulation of fructose 1,6-diphosphate transformation in tissues].
    Alekseeva NV; Alekseev VS
    Ukr Biokhim Zh (1978); 1991; 63(3):85-9. PubMed ID: 1926592
    [No Abstract]   [Full Text] [Related]  

  • 55. The metabolism of fructose-phenylalanine in the rat.
    Perkins EG; Baker DH; Johnson GH; Makowski E
    Prog Food Nutr Sci; 1981; 5(1-6):229-42. PubMed ID: 6798631
    [No Abstract]   [Full Text] [Related]  

  • 56. [Pharmacokinetics of phenol following phenol block].
    Nomoto Y
    Masui; 1986 Jan; 35(1):28-34. PubMed ID: 3712730
    [No Abstract]   [Full Text] [Related]  

  • 57. [The fructose-2,6-diphosphate system and diabetes mellitus].
    Korovkin BF; Beliaeva NF; Viktorova LN; Golubev MA; Gorodetskiĭ VK; Markova MS; Saiapin AV; Stvolinskaia NS
    Klin Lab Diagn; 1994; (2):21-4. PubMed ID: 8032748
    [No Abstract]   [Full Text] [Related]  

  • 58. Kinetics of 2,4,6-trichlorophenol in different organs of the rat.
    Pekari K; Boudène C; Aitio A
    Arch Toxicol; 1986 May; 59(1):41-4. PubMed ID: 3741142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ligand-induced conformations of rat liver hexokinase II--sigmoid inhibition by FDP.
    Kelkar SM; Nadkarni GB
    Indian J Biochem Biophys; 1983 Dec; 20(6):357-61. PubMed ID: 6674121
    [No Abstract]   [Full Text] [Related]  

  • 60. [The kinetics of pindolol distribution in the rat].
    Barrigón S
    Arch Farmacol Toxicol; 1984 Aug; 10(2):83-94. PubMed ID: 6517622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.